J. U. Lovegrove

559 citations
16 papers · 430 indexed · h-index 10
Topics
Protease and Inhibitor Mechanisms (5 papers)Genomic variations and chromosomal abnormalities (2 papers)Healthcare Policy and Management (2 papers)

In The Last Decade

J. U. Lovegrove

16 papers receiving 417 citations

Peers

J. U. Lovegrove
Comparison fields: 5 of 75
  • Molecular Biology 138
  • Pulmonary and Respiratory Medicine 108
  • Cancer Research 75
  • Epidemiology 72
  • Surgery 52
Replace Glynis Frans with:
Glynis Frans Belgium
Robin Bechhofer United States
Poorya Amini Switzerland
Mabood Qureshi Canada
Beth A. Schodin United States
Anna Ragaz United States
H Ørjasæter Norway
Yinan Shen China
Jean‐Michel Raoult France
Christine N. Booth United States
J. U. Lovegrove relative to Glynis Frans Belgium Glynis Frans's profile →
Citations per field
00.5×4.7×
Glynis Frans · 1×
Citations per year

Countries citing papers authored by J. U. Lovegrove

Since Specialization
Citations

This map shows the geographic impact of J. U. Lovegrove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. U. Lovegrove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. U. Lovegrove more than expected).

Fields of papers citing papers by J. U. Lovegrove

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. U. Lovegrove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. U. Lovegrove. The network helps show where J. U. Lovegrove may publish in the future.

Co-authorship network of co-authors of J. U. Lovegrove

This figure shows the co-authorship network connecting the top 25 collaborators of J. U. Lovegrove. A scholar is included among the top collaborators of J. U. Lovegrove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. U. Lovegrove. J. U. Lovegrove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 9
2 100
3 41
4 25
5 39
6 13
7 3
8 4
9 61
10 46
11 7
12 14
13 5
14 47
15 15
16 1

About J. U. Lovegrove

J. U. Lovegrove is a scholar working on Cancer Research, Genetics and Hematology, having authored 16 papers that have together received 430 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (5 papers), Genomic variations and chromosomal abnormalities (2 papers) and Healthcare Policy and Management (2 papers). The work is most often cited by research in Cancer Research (75 citations), Statistics, Probability and Uncertainty (31 citations) and Hematology (38 citations). J. U. Lovegrove has collaborated with scholars based in United Kingdom, Netherlands and India. Frequent co-authors include David Whitehouse, D. A. HOPKINSON, S Gallivan, Megan Griffith, Charles D. Pusey, G. Gaskin, D. B. Whitehouse, K. Watterson, J. Stark and Oswaldo Valencia. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026